Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125221381 | 12522138 | 1 | I | 2016 | 20160624 | 20160701 | 20160701 | EXP | US-ASTRAZENECA-2016SE70810 | ASTRAZENECA | 79.00 | YR | F | Y | 0.00000 | 20160701 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125221381 | 12522138 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | Y | U | 21929 | |||||||||
| 125221381 | 12522138 | 2 | SS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 100/25 UG, ONCE DAILY | Y | U | 0 | INHALATION POWDER | |||||||
| 125221381 | 12522138 | 3 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Unknown | U | 0 | INHALATION POWDER | |||||||||
| 125221381 | 12522138 | 4 | SS | ALBUTEROL. | ALBUTEROL | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125221381 | 12522138 | 1 | Asthma |
| 125221381 | 12522138 | 2 | Asthma |
| 125221381 | 12522138 | 3 | Asthma |
| 125221381 | 12522138 | 4 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125221381 | 12522138 | LT |
| 125221381 | 12522138 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125221381 | 12522138 | Adverse drug reaction | |
| 125221381 | 12522138 | Asthma | |
| 125221381 | 12522138 | Cold sweat | |
| 125221381 | 12522138 | Cough | |
| 125221381 | 12522138 | Dizziness | |
| 125221381 | 12522138 | Drug ineffective | |
| 125221381 | 12522138 | Dyspnoea | |
| 125221381 | 12522138 | Headache | |
| 125221381 | 12522138 | Ill-defined disorder | |
| 125221381 | 12522138 | Malaise | |
| 125221381 | 12522138 | Oropharyngeal pain | |
| 125221381 | 12522138 | Paralysis | |
| 125221381 | 12522138 | Pharmacophobia | |
| 125221381 | 12522138 | Respiratory arrest | |
| 125221381 | 12522138 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125221381 | 12522138 | 2 | 201603 | 201604 | 0 | |
| 125221381 | 12522138 | 3 | 20160226 | 0 |